Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTET USA)

NCT03640312 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03640312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03640312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTET USA)
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
August 30, 2019
Completion date
July 31, 2024
Enrollment
62 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension